Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer.

about

Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer.

Item

http://www.wikidata.org/entity/Q38603374

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Therapy-related acute myeloid ...... treatment for thyroid cancer.

@en

type

Item

label

Therapy-related acute myeloid ...... treatment for thyroid cancer.

@en

prefLabel

Therapy-related acute myeloid ...... treatment for thyroid cancer.

@en

P1476

Therapy-related acute myeloid ...... treatment for thyroid cancer.

@en

P2093

Adetokunbo Oluwasanjo

http://www.w3.org/2001/XMLSchema#string

Anene Ukaigwe

http://www.w3.org/2001/XMLSchema#string

Olatunji Alese

http://www.w3.org/2001/XMLSchema#string

Ranjan Pathak

http://www.w3.org/2001/XMLSchema#string

P2860

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Myeloid Sarcoma of the Uterine Cervix as Presentation of Acute Myeloid Leukaemia after Treatment with Low-Dose Radioiodine for Thyroid Cancer: A Case Report and Review of the Literature.

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series.

Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.

Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk.

Induction of leukemia by 131-I treatment of thyroid carcinoma.

A case of therapy-related acute myeloid leukemia with inv(16)(p13.1q22) after single low-dose iodine-131 treatment for thyroid cancer

Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.

Radioprotective agents for the prevention of side effects induced by radioiodine-131 therapy.

P2888

s10552-015-0682-5

P304

143-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10552-015-0682-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26453198

http://www.w3.org/2001/XMLSchema#string

P921

therapy-related acute myeloid leukemia